← 홈

Antibody · 류마티스관절염

65개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 65개
AntibodystaleAbbViePhase 2

adalimumab (Humira, Adalimumab, current formulation)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleAbbViePhase 2

adalimumab (Humira, Adalimumab, new formulation)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodyAbbViePhase 2

adalimumab (Humira, Adalimumab-800CW)

IBD; Rheumatoid Arthritis · IBD

#IBD#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleMerck KGaA, Darmstadt, GermanyPhase 2

Atacicept (Atacicept)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleUniversity of CagliariPreclinical

Belimumab in SLE patients / Rituximab in RA patients (Belimumab in SLE patients / Rituximab in RA patients)

Systemic Lupus Erythematosus; Rheumatoid Arthritis · Systemic Lupus Erythematosus

#SystemicLupusErythematosus#Antibody#Preclinical#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleShanghai Biomabs Pharmaceutical…Phase 3

CMAB008 (CMAB008)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleUniversity of Illinois at Chica…Approved

CDP870, tradename Cimzia (Certolizumab pegol, Certolizumab pegol (CDP870, tradename Cimzia))

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Approved#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleAbbViePhase 3

adalimumab (Humira, Double-blind adalimumab)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 3

GP2013 - A Proposed biosimilar rituximab (GP2013 - A Proposed biosimilar rituximab)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleBiogenPhase 2

rituximab (IDEC-C2B8, IDEC-C2B8 (rituximab))

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleJanssenPhase 3

Infliximab (INF, Infliximab, Infliximab (INF) + MTX, DB)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenPhase 3

MTX (Infliximab + methotrexate, Infliximab + methotrexate (MTX))

Arthritis, Rheumatoid · Arthritis, Rheumatoid

#ArthritisRheumatoid#Antibody#Phase3#항체#면역항체+4
임상시험 1상태 ACTIVE
AntibodystaleJanssenPhase 3

Infliximab Control (Infliximab Control)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleJanssenPhase 3

Infliximab Increased Dose (Infliximab Increased Dose)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleJanssenPhase 3

Infliximab Increased Frequency (Infliximab Increased Frequency)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleJanssenPreclinical

Infliximab group (Infliximab group)

Rheumatoid Arthritis（RA） · Rheumatoid Arthritis（RA）

#RheumatoidArthritisRA#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenApproved

Infliximab, methylprednisolone, methotrexate (Infliximab, methylprednisolone, methotrexate)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Approved#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenPreclinical

adalimumab (Humira, Infliximab: Adalimumab; Etanercept;)

Rheumatoid Arthritis; Inflammatory Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Preclinical#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleJanssenPreclinical

Infliximab; observational study (Infliximab; observational study)

Spondylitis, Ankylosing; Arthritis, Rheumatoid · Spondylitis, Ankylosing

#SpondylitisAnkylosing#Antibody#Preclinical#항체#면역항체+5
임상시험 1상태 ACTIVE
AntibodystaleJanssenApproved

Innovator infliximab (Innovator infliximab)

Rheumatoid Arthritis; Spondyloarthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Approved#항체#면역항체+3
임상시험 1상태 ACTIVE

2 / 4 페이지

← 이전다음 →